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g from the aorta of ApoE-/-mice.
RESULTS Our results show that the percentages of CD4þ IFN-gþ from
the spleens were decreased after treatment with different dose of
Danlou Tablet groups compared to the model group, greatly decreased
with high-dose DLT group(model group vs DLT-H group :13.802.00
vs 8.231.65, p < 0.01). Immunohistochemical staining and real-time
PCR for aorta revealed that the IFN-g was decreaed with Danlou
Tablet dose-dependent(the fold changes of IFN-g:model group vs
DLT-L group: 2.960.87 vs 2.101.28, P < 0.05; model group vs DLT-M
group: 2.960.87 vs1.680.40, P < 0.01; model group vs DLT-H group:
2.960.87 vs1.240.15, P < 0.01). The ﬁndings suggest that Danlou
Tablet could markedly attenuates progression of atherosclerosis by
decreasing the expression of IFN-g and suppressing inﬂammation.
CONCLUSIONS Our ﬁndings demonstrate that Danlou Tablet could
decrease the expression of IFN-g or restain the artery-inﬁltrating T
cells, especially the Th1 cells activated or suppressed inﬂammation
and attenuated progression of atherosclerosis via weaken the Th1-
IFN-g pathway.
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OBJECTIVES To investigate the effects of Guizhi decoction (a long-
used harmonic prescription in traditional Chinesemedicine) on cardiac
autonomic neuropathy (CAN) in streptozotocin (STZ)-induced diabetic
rats. With the establishment of chemical sympathetic sprouting and
sympathectomy rat models, we explored the protective mechanism of
Guizhi decoction on the cardiac sympathetic remodeling.
METHODS
1) After induction of diabetic rats with STZ for four weeks, mecobalamin
and Guizhi decoction were administered to the STZ rats for 4 weeks.
Heart rate variability (HRV) were recorded, and contents of nerve
growth factor (NGF), growth associated protein 43(GAP-43) and
ciliary neurotrophic factor (CNTF) in myocardium as well as the
density of tyrosine hydroxylase (TH) and choline acetyltransferase
(ChAT) in the right atrium (RA) were respectively measured using
ELISA and immunohistochemical staining.
2) Cardiac sympathetic sprouting rats were induced with 4-Methyl-
catechol (4-MC) for 30 days. Metoprolol and Guizhi decoctions were
separately administered to the rats for 30 days. Meanwhile, we
established chemical sympathectomy rats with 6-Hydroxydopamine
(6-OHDA) for 3 days. Mecobalamin and Guizhi decoctions were
separately administered to the rats for 10 days. Contents of GAP-43,
TH and ChAT in the cardiac tissue were examined and distribution of
TH-positive nerve ﬁbers was observed. Besides, serum myocardial
enzyme levels and changes of myocardial morphology were observed
in 6-OHDA rats.
RESULTS
1) STZ rats demonstrated autonomic nerve dysfunction. Compared with
the model groups, rats treated with Guizhi decoction had higher HRV
parameters such as SDNN, RMSSD, LF, HF and TP, as well as
decreased LF/HF (P <0.05); the TH-positive nerve ﬁber decreased
while the ChAT-positive expression increased (P <0.05); contents of
GAP-43 and CNTF increased while NGF decreased (P <0.05). It sug-
gested that Guizhi decoction improved vagal nerve dysfunction in
STZ diabetic rats and mitigated the autonomic neuropathy.
2) 4-MC caused cardiac sympathetic sprouting. Compared with the
model group, contents of TH and GAP-43 in cardiac tissue decreased
while ChAT unchanged in Guizhi decoction group, indicating that
Guizhi decoction can effectively suppress the 4-MC-induced sympa-
thetic sprouting.
3) 6-OHDA caused chemical sympathectomy. Compared with the model
group, contents of TH and GAP-43 in myocardium of Guizhi decoction
group elevated and ChAT kept unchanged; the serum levels of
myocardial enzymes, the cardiac histopathology and heart function
were improved, suggesting that Guizhi decoction effectively allevi-
ated sympathetic injury and myocardial injury related to sympathetic
denervation.
CONCLUSIONS Guizhi decoction effectively alleviated diabetic CAN.
Guizhi decoction demonstrated double-sided regulation on cardiacsympathetic sprouting and sympathetic denervation which may be
one of the important mechanism of the improvement of Guizhi
Decoctionon on diabetic cardiomyopathy.
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OBJECTIVES Endothelial dysfunction is a central hallmark of dia-
betes, delaying endothelial healing in diabetic patients following an-
gioplasty. The epigenetic abnormalities are increasingly considered to
be relevant to the pathogenesis of diabetic complications. We here
investigated the therapeutic potential of histone demethylase JMJD2A
and its substrate histone H3 lysine 9 trimethylation (H3K9me3) on re-
endothelialization in a vascular injury model of diabetic rats.
METHODS JMJD2A inhibition was achieved either by chemical in-
hibitor 2,4-pyridinedicarboxylic acid (2,4-PDCA) or small interfering
RNA (siRNA) both in vitro and in vivo studies. In vitro, we examined
the proliferative, migratory and angiogenic capacities of human um-
bilical vein endothelial cells (HUVECs) in response to high glucose
(HG). Flow cytometry was performed to detect the apoptosis and the
expressions of apoptosis-associated genes were assessed by real-time
PCR and western blot. Immunoprecipitation (ChIP) assay was con-
ducted to examine the modiﬁcation of H3K9me3 at related genes’
promoters. In vivo, common carotid artery balloon injury was devel-
oped in high-fat diets (60% fat) and low-dose streptozotocin (35 mg/
kg) induced diabetic rats. The reendothelialization was quantiﬁed
withEvens blue staining and immunohistochemical staining.
RESULTS Both in HG-treated HUVECs and balloon–injured arteries of
diabetic rats, the global expression of JMJD2A was increased whereas
H3K9me3 was decreased. In vitro, JMJD2A inhibition either by 2,4-
PDCA (0.5mM) or by siRNA (20nM) accelerated HUVECs proliferation,
migration and tube formation in response to HG, accompanied by
reduced expression of TNF-a and suppressed apoptosis (down-
regulated caspase3, caspase9, Bax and upregulated Bcl-2). ChIP assay
indicated that the potential mechanism was relevant to the increased
H3K9me3 at the promoter of TNF-a and then the transcriptional
silencing of TNF-a. Complementary in vitro studies showed that
JMJD2A inhibition promoted reendothelialization in diabetic rats.
CONCLUSIONS JMJD2A inhibition promotes reendothelialization af-
ter arterial injury in diabetic rats via accelerated proliferation,
migration and suppressed apoptosis of endothelial cells.
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OBJECTIVES Pioglitazone, a clinically used insulin sensitizer, has
appeared to have an anti-atherosclerotic effect. The aims of this study
is to determine whether pioglitazone can reduce the number of plaque
thrombosis incidences and whether decreasing plaque inﬂammation
is the mechanism by which pioglitazone reduces plaque thromboses
in an atherosclerotic model.
METHODS 20 male New Zealand white rabbits were randomly divided
into two groups: Atherosclerosis group (Group A, n¼10) and middle-
pioglitazone-treated group (Group P, n¼10). Atherosclerosis was
induced in all rabbits by intermittent high-cholesterol diet and
endothelial denudation. From the ninth week, the rabbits in group P
received pioglitazone (10 mg$kg-1$d-1) in addition to the diet, till the
end of experiment. PET/CT scans were performed at 8 week and 18
week in all survival rabbits, to obtain FDG uptake parameters (mean
standardized uptake value, SUVmean and maximal standardized up-
take value, SUVmax). Concomitantly, serum samples were obtained
for analysis of blood glucose (G), triglycerides (TG), total cholesterol
(Ch), HDL, LDL, hs-CRP and matrix metalloproteinase-9 concentration
(MMP-9). All survival rabbits underwent 2 pharmacological triggerings
to induce plaque rupture at 18 week. After pharmacological triggering,
all rabbits were euthanatized, aortic histopathological analysis were
performed.
RESULTS 20 male New Zealand white rabbits were randomly
divided into two groups: Atherosclerosis group (Group A, n¼10) and
